Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Phio Pharmaceuticals Corp. Common Stock (PHIO)

Pharmaceutical Preparations

https://www.phiopharma.com

Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others.

257 SIMARANO DRIVE, SUITE 101
MARLBOROUGH, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/10/2012

Market Cap

1,409,700

Shares Outstanding

2,440,000

Weighted SO

4,573,699

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

ZURA --.--%

APGN --.--%

EFTR --.--%

IMMX --.--%

CNSP --.--%

ZVSA --.--%

VECT --.--%

AVRO --.--%

CWBR --.--%

Beta

1.4490

Last Div

0.0000

Range

2.4-29.07

Chg

0.2431

Avg Vol

34155

Mkt Cap

1409700

Exch

NASDAQ

Country

US

Phone

508 767 3861

DCF Diff

2.1221

DCF

4.0579

Div Yield

0.0000

P/S

46.9900

EV Multiple

0.3824

P/FV

0.3736

Div Yield %

0.0000

P/E

-0.1625

PEG

0.0004

Payout

0.0000

Current Ratio

3.4747

Quick Ratio

3.4747

Cash Ratio

3.0847

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

978.2000

CCC

-978.2000

Gross Margin

-3.1667

Op Margin

-289.2000

Pretax Margin

-289.1667

Net Margin

-289.1667

Eff Tax Rate

0.0011

ROA

-1.6380

ROE

-1.4268

ROCE

-2.2995

NI/EBT

1.0000

EBT/EBIT

0.9999

EBIT/Rev

-289.2000

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

0.0000

CF/Debt

0.0000

Equity Multi

1.4037

Rec Turnover

0.0000

Pay Turnover

0.3731

Inv Turnover

0.0000

FA Turnover

30.0000

Asset Turnover

0.0057

OCF/Share

-17.7542

FCF/Share

-17.7542

Cash/Share

9.2084

OCF/Sales

-301.9333

FCF/OCF

1.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.3736

P/B

0.3736

P/S

46.9900

P/E

-0.1625

P/FCF

-0.1556

P/OCF

-0.1556

P/CF

-0.1556

PEG

0.0004

P/S

46.9900

EV Multiple

0.3824

P/FV

0.3736

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. May 17, 13:00 Phio Pharmaceuticals Secures New Investor GlobeNewswire Inc. May 17, 13:00 Phio Pharmaceuticals Secures New Investor GlobeNewswire Inc. May 17, 13:00 Phio Pharmaceuticals Secures New Investor GlobeNewswire Inc. May 17, 13:00 Phio Pharmaceuticals Secures New Investor GlobeNewswire Inc. May 17, 13:00 Phio Pharmaceuticals Secures New Investor Benzinga Dec 06, 14:43 Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session PennyStocks Dec 05, 17:10 Penny Stocks To Buy Now? 5 Under $5 To Watch This Week GlobeNewswire Inc. Nov 09, 07:30 Phio Pharmaceuticals Announces First US Patient Enrolled in Phase 1B Clinical Trial with Intratumoral PH-762 anti-PD-1 Therapy for Treatment of Skin Carcinomas

Revenue Product Segmentation